Medical devices company Aran Biomedical revealed on Monday the appointment of Todd Blair as vice president of its Sales and Business Development (US) to meet and manage the growing demand for its implantable biomaterial product solutions.
Effective 1 July 2020, Blair will support, identify and develop the company's new business opportunities into sustainable and long-term partnerships, lead internal teams on proposal and product solution development as well as oversee the sales and business development activities in the US marketplace with a primary focus on the Orthopaedic, General Surgery and Vascular fields.
Most recently, Blair has served as vice president of Corporate Strategy at Heraeus Medical Components.
The company said Todd brings to the new position more than 20 years of experience in sales and business development within the life sciences contract manufacturing industry, with a focus on Bio-Textiles, Nitinol devices and polymeric components.
Maze Therapeutics reports positive Phase 2 data for MZE829 in patients with AMKD
Andel launches new direct-to-employer medication platform for GLP-1s
Dexcom highlights new diabetes outcomes and product roadmap at ATTD 2026
Cedar Health Research opens new embedded research site within Texas Native Health
AstraZeneca agrees obesity and type 2 diabetes collaboration with CSPC
Alvotech reaches global settlement over aflibercept biosimilar patents
MedPal AI announces approval to supply Eli Lilly medicines in UK
Hanmi Pharmaceutical signs distribution agreement with Laboratorios Sanfer in Mexico
Viking Therapeutics publishes Phase 2 data showing up to 14.7% weight loss with VK2735